We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
51982 683 3 CRSP
Emcee:  Biomaven Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
49680Exactly? Ashley: They lost less last quarter than a year before Art: I A.J. Mullen-3/1/2018
49679"Net loss for the fourth quarter of 2017 was $22.1 million, or $0.27 per shArt Bechhoefer-3/1/2018
49678Was pointed out to me in prior years 10k same wording before results so probablyghmm-2/28/2018
49677Thanks for the explanation regarding their improved costs. The retention of pamA.J. Mullen-2/28/2018
49676>>They lost less last quarter than a year before That's because they Biomaven12/28/2018
49675No, I was looking at the total loss for the company in their press release; NetA.J. Mullen-2/28/2018
49674It's true that they "lost less last quarter than a year before," bArt Bechhoefer-2/28/2018
49673Only negative I saw was longer time to complete Roxa Ph 3s for US. DCF issue notRobohogs-2/28/2018
49672The market didn't like results that FGEN posted yesterday or their call. ThA.J. Mullen-2/28/2018
49671>>the FB algo pricing was set to drive more engagement, not less. Of courBiomaven-2/28/2018
49670[OT]>>you need a script<< I was surprised I couldn't even buy cidos-2/28/2018
49669This is where I used to love having access to broad general background research Robohogs-2/27/2018
49668>>If the clicks are being driven by ever-smarter targeting of ads, wouldn&Biomaven-2/27/2018
49667[OT/FB]— FB has nearly "solved" advertising by allowing effective miDewDiligence_on_SI-2/27/2018
49666So the contrary view is that FB has nearly "solved" advertising by allBiomaven-2/27/2018
49665Great points. My biggest point is on average usage. Company is under pressure toRobohogs-2/27/2018
49664[OT/FB]—I think long-term short of Facebook probably creates nice gains here. LoDewDiligence_on_SI-2/27/2018
49663Social mood toward big tech. Business Model issues. I think longterm short of FaRobohogs-2/27/2018
49662Yes, you need a script. >>HbA1B 4.8 and fasting glucose 64 More carbs! Biomaven-2/27/2018
49661re: Continuous glucose monitor I've been interested in doing this for the sjb118-2/27/2018
49660So I'm trying the new Abbvie continuous glucose monitor - more as a science Biomaven32/27/2018
49659>> the effectiveness of the vaccine against H3N2 in children 6 months to 8scaram(o)uche12/26/2018
49658The CSO of ExpreS2ion Biotech Holding and CEO of its joint-venture AdaptVac Willloparn-2/23/2018
49657I also suggest that you listen to Rudy Tanzi's presentation starting at ~ 56software salesperson-2/21/2018
49656Beta-Amyloid is Most Common Target Despite a history of failures, 30 drugs in csoftware salesperson-2/21/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):